Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Amortizatization of Intangibles: 2019-2024

Historic Amortizatization of Intangibles for Krystal Biotech (KRYS) over the last 5 years, with Dec 2024 value amounting to $747,000.

  • Krystal Biotech's Amortizatization of Intangibles rose 11.17% to $209,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $818,000, marking a year-over-year increase of 3.68%. This contributed to the annual value of $747,000 for FY2024, which is 17.37% down from last year.
  • As of FY2024, Krystal Biotech's Amortizatization of Intangibles stood at $747,000, which was down 17.37% from $904,000 recorded in FY2023.
  • Krystal Biotech's 5-year Amortizatization of Intangibles high stood at $920,000 for FY2021, and its period low was $742,000 during FY2022.
  • In the last 3 years, Krystal Biotech's Amortizatization of Intangibles had a median value of $747,000 in 2024 and averaged $797,667.
  • In the last 5 years, Krystal Biotech's Amortizatization of Intangibles decreased by 19.35% in 2022 and then increased by 21.83% in 2023.
  • Yearly analysis of 4 years shows Krystal Biotech's Amortizatization of Intangibles stood at $920,000 in 2021, then decreased by 19.35% to $742,000 in 2022, then grew by 21.83% to $904,000 in 2023, then decreased by 17.37% to $747,000 in 2024.